Centre for Commercialization of Regenerative Medicine

Welcome

CCRM is a Canadian, not-for-profit organization supporting the development of foundational technologies that accelerate the commercialization of stem cell- and biomaterials-based products and therapies. CCRM is supported by the Centres of Excellence for Commercialization and Research (CECR) Program.

Events List

OSCI External Seminar Series

Mon May 07 2012

Toronto, Ontario
OSCI: Stem Cell Rounds

Wed Sep 12 2012

Toronto, Ontario

Workshops Register Now

Cellular Therapies Manufacturing and Clinical Trials in Canada

Mon Jun 25 2012

Rosebrugh Building*, Room 211 164 College Street, Toronto, ON (Subject to change! Please check!)

Science, Industry & Business News

May 15/12	Stem cell co Gamida Cell raises $10M with partner Teva Pharmaceuticals.
May 14/12	Tissue regeneration co Regentis Biomaterials raises $10M.
May 12/12	Celgene announces three phase III Revlimid trials in newly diagnosed MM patients.
May 10/12	Study identifies cell subtypes for potential personalized cellular therapies.
May 9/12	Two cell transplantation studies impact dental stem cell research for therapeutic purposes.
May 4/12	New muscular dystrophy treatment approach developed using human stem cells.
May 4/12	UCLA stem cell research may help patients with neuromuscular disorders.
May 4/12	Royal DSM to acquire biomaterials R&D leader Kensey Nash.
May 3/12	Taiwan, EU promote biomaterial collaboration.
Apr 26/12	From embryonic stem cells, a sperm replacement and easier path to genetic modification.